On June 26, the United Nations Office on Drugs and Crime (UNODC) released its 2026 World Drug Report. Drug-war hardliners who (wrongly) credit recent overdose drops to tougher enforcement won’t like this report, which the agency summarized in a press release.
The latest report concludes that global illicit drug markets continue to adapt and expand. Traffickers increasingly exploit new technologies, shifting trade routes, geopolitical instability, and a growing array of synthetic drugs to evade law enforcement and reach new markets. The report estimates that 331 million people used illicit drugs in 2024 and warns that drug markets have become more diverse and resilient, increasingly driven by synthetic substances.
The report’s findings corroborate several observations that underlie my long-standing thesis:
Drug markets adapt rather than disappear.
The report emphasizes that traffickers rapidly adjust to enforcement pressure by shifting production methods, trafficking routes, and distribution techniques. As I wrote in testimony for the Senate Judiciary Committee in 2025, “as the US has pressured China to curtail precursor production, precursors are now coming from labs in India, Myanmar, other parts of Southeast Asia, and even Canada.” The press release states:
The 2022 drug ban in Afghanistan has continued to severely constrain the illicit production of opium and heroin. Although production in Myanmar rose from 420 tons in 2021 to over 1,000 in 2025, the increase in the country (together with quantities produced in other countries monitored by UNODC, i.e., Laos and Mexico) does not offset the declines in Afghanistan, which in 2022 produced more than 6,000 tons of opium.
The increasing availability of novel synthetic opioids such as fentanyls, nitazenes and orphines on the market suggests that traffickers are searching for alternatives to heroin. A turn away from plant-based opiates toward synthetics could cause a permanent shift in the global opioid market, with ramifications on how these drugs are used and the harms therein.
Synthetic drugs become increasingly attractive under prohibition.
Synthetic substances are often easier to manufacture, require less agricultural land, are more concentrated, and are easier to conceal and transport than plant-based drugs. These characteristics make them especially well-suited to illicit markets. Fentanyl was among the first synthetic opioids to enter the underground market, but toxicology labs are reporting an increasing number of overdoses involving chemically unrelated synthetics that require different precursor ingredients, such as nitazenes and orphines like cyclorphine.
Innovation is relentless.
The report describes an “unprecedented spike” in novel psychoactive substances, underscoring that producers continually develop new compounds in response to market pressures and regulatory controls. Again, from the press release:
Illicit drug manufacturers continue to invent new synthetic drugs in attempts to skirt regulations and avoid detection, with five times more drug types found in seizures in 2024 than before 2000. The number of new psychoactive substances (NPS) reported to have been circulating in drug markets, for example, reached 755 in 2024, with 118 of these substances reported for the first time.
The UNODC is not a libertarian organization. It is the UN agency charged with supporting and implementing the international drug control treaties and assisting member states in carrying them out.
For years, I have argued that prohibition doesn’t eliminate drugs people want to use. It changes the incentives. As enforcement intensifies, producers and traffickers respond by developing more potent, more compact, and easier-to-conceal substances. The result is what prohibition critics have long called the “Iron Law of Prohibition”: the harder the enforcement, the harder the drugs.
Ironically, the latest UNODC report provides fresh evidence consistent with that argument. It describes traffickers exploiting new technologies, geopolitical instability, and an “unprecedented spike” in novel synthetic drugs to evade enforcement and expand into new markets. Far from disappearing under pressure, illicit drug markets continue to innovate. That innovation increasingly produces drugs that are more concentrated, more unpredictable, and more dangerous.
The report emphasizes that every major illicit drug market is becoming more global, more innovative, and more resilient, despite decades of increasingly aggressive enforcement. Methamphetamine production and trafficking have spread well beyond their traditional strongholds into the Middle East, Africa, Europe, and the Pacific. Cocaine production has quadrupled over the past decade as trafficking organizations expand into new markets in Africa and Asia. Even cannabis—long considered largely regional because it can be grown almost anywhere—is increasingly traded across continents, with North America emerging as a major source for international trafficking.
The UNODC did not intend to validate my longstanding arguments against prohibition. Yet its latest report does exactly that. Governments can prohibit drugs, but they cannot prohibit demand. They can only change the incentives facing suppliers. Those incentives reward innovation, resilience, and increasingly potent, compact, and dangerous drugs. After decades of escalating enforcement, the evidence continues to point in the same direction: prohibition has not defeated the market. It has reshaped it.